Screener
Jazz Pharmaceuticals JAZZ Goodwill
Goodwill at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The source filing: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001232524-26-000025
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Property, plant and equipment, net | 203.1 | 199.9 |
| Operating lease assets | 55.8 | 58.9 |
| Intangible assets, net | 4,203.8 | 4,429.5 |
| Goodwill | 1,805.0 | 1,829.3 |
| Deferred tax assets, net | 907.0 | 869.1 |
| Deferred financing costs | 7.1 | 7.6 |
| Other non-current assets | 94.7 | 99.0 |
| Total assets | $11,859.6 | $11,659.3 |
Item 1.Financial Statements
FAQ
- What is Jazz Pharmaceuticals's goodwill?
- Jazz Pharmaceuticals (JAZZ) reported goodwill of $1.81B in Q1 2026.
- How has Jazz Pharmaceuticals's goodwill changed year-over-year?
- Jazz Pharmaceuticals's goodwill increased by 2.6% year-over-year, from $1.76B to $1.81B.
- What is the long-term trend for Jazz Pharmaceuticals's goodwill?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's goodwill has grown at a 13.8% compound annual growth rate (CAGR), from $958.3M to $1.83B.
- What does goodwill mean?
- The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.
Ask your AI about Jazz Pharmaceuticals's goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude